4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-046844
Interim CEO & General Counsel gave up 8,851 shares (to pay taxes)
- Interim CEO & General Counsel acquired 20,834 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2023-04-14 | Option exercise | +20,834 | 69,718 | D | ||
| Vogt Frederick G Interim CEO & General Counsel | 2023-04-14 | Shares withheld for taxes | −8,851 | $5.64 | $49,920 | 60,867 | D |
| Derivatives | |||||||
| Vogt Frederick G Interim CEO & General Counsel | 2023-04-14 | Option exercise · Restricted Stock Units | −20,834 | 145,841 | D | ||
Loading xslF345X04/tm2313085-3_4seq1.xml…